Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation - Post-hoc analysis from a prospective imaging trial.

By A. Rühle, A. Grosu, N. Wiedenmann, R. Stoian, E. Haehl, C. Zamboglou, D. Baltas, M. Werner, G. Kayser, N. Nicolay. 2021